Target intelligence / Profile preview

Angiopoietin-like protein 8 (ANGPTL8)

Target
ANGPTL8
Molecular classification
Angiopoietin-like protein
01

Overview

Angiopoietin-like protein 8 (ANGPTL8), also known as betatrophin, is a secreted glycoprotein that regulates serum triglyceride levels by modulating lipoprotein lipase (LPL) activity. It acts as an inhibitor of LPL and forms complexes with other angiopoietin-like proteins, such as ANGPTL3 and ANGPTL4, to regulate lipid metabolism. While there has been interest in its potential role in promoting pancreatic beta-cell proliferation and insulin release, this remains controversial. Dysregulation of ANGPTL8 has been associated with metabolic disorders such as liver steatosis and potentially type II diabetes. It has also shown potential therapeutic effects in experimental models of Adriamycin-induced cardiomyopathy.

Other names
Betatrophin
02

Mechanism of action

Inhibits lipoprotein lipase (LPL) activity by forming complexes with ANGPTL3 or ANGPTL4, promoting LPL dissociation into inactive monomers.

03

Biological functions

Regulation of lipid metabolismModulation of lipoprotein lipase (LPL) activityRegulation of triglyceride levelsRegulation of glucose homeostasisPossible beta-cell proliferation
04

Disease associations

Metabolic disordersLiver steatosisType II diabetesCardiomyopathy
05

Safety considerations

Controversial role in beta-cell proliferation in humans.Dysregulation associated with metabolic diseases.

Beyond the preview

Go deeper on Angiopoietin-like protein 8 (ANGPTL8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiopoietin-like protein 8 (ANGPTL8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call